Neurology
Latest News
Medicare to pay for at-home dementia care coordination
The program is voluntary and will be open to Medicare-enrolled clinicians and other providers who can assemble an interdisciplinary care team and...
Latest News
Folic acid supplementation for birth defects reaffirmed
Primary care physicians play a key role in patient education and ensuring that all patients receive adequate folic acid.
From the Journals
Daily aspirin for stroke prevention in healthy elderly should be avoided
Data from a large randomized trial suggest that aspirin increases bleeding risk and is ineffective for primary stroke prevention in the elderly....
From the Journals
Concussion may not affect IQ in children
“The message I give parents is that most kids recover within 2-4 weeks.”
Latest News
Research casts doubt on value of daily aspirin for healthy adults
The U.S. Preventive Services Task Force recommends that low-dose aspirin should not be prescribed for preventing a first heart attack or stroke in...
From the Journals
Why scratching is so contagious
“Contagious behavior is actually a very efficient way to inform other animals of what’s coming.”
Latest News
Tooth loss, gum disease tied to hippocampal atrophy
For those with severe gum disease, each additional lost tooth was associated with a faster rate of brain shrinkage, equivalent to 1.3 years of...
Latest News
New Alzheimer’s drugs: Setting realistic expectations
Most patients living with Alzheimer’s disease will not qualify for treatment with these drugs, and those who do may suffer serious side effects....
From the Journals
No cognitive benefit from meditation, learning a language?
The findings contradict the researchers’ earlier work that found mindfulness meditation boosted cognitive function in older adults with subjective...
Feature
Over-the-counter switches improve access but come with risks
But eliminating the need for a refill prescription may encourage uptake of statins. “We spend a ton of time refilling statins and it’s a headache...
Conference Coverage
Oral tau inhibitor continues to show promise in Alzheimer’s
“This is the first tau aggregation inhibitor to reach the phase 3 stage of development and to produce results like this.”